v3 Template
K

Kernal Bio

Biotechnology ~360 employees
Founded
--
Employees (Est.)
~360
18 leaders known
Total Funding
$48.0M
Funding Rounds
1
Last Funding
2025-10-07

About Kernal Bio

Kernal Biologics is a biotechnology company focused on engineering cells inside the body through targeted delivery and selective translation. Their mission is to develop scalable in vivo cell therapies, particularly for cancer and autoimmune diseases, by programming cells directly within the body using mRNA therapeutics and AI-driven platforms.

Products & Services

mRNA Therapeutics Platform:A platform for in vivo cell therapies that delivers sequences to specific tissues and cells with precise targeting and selective translation, enabling scalable CAR-T therapies for cancer and autoimmune diseases.

Specialties

mRNA Therapeutics In Vivo Cell Therapies CAR-T Therapies AI-Driven Drug Development Cancer Treatment Autoimmune Disease Treatment

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Grant
T: -
FT: Grant 		A: 48000000
MR: -
FA: up to $48 million
FAN: 48000000 		D: 2025-10-07
FD: 2025-10-07 		1 investors
Grant Latest
2025-10-07
$48.0M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

Y

Yusuf Erkul

Chief Executive Officer & Cofounder

LinkedIn (Pro only)
B

Burak Yilmaz

President & Cofounder

LinkedIn (Pro only)
M

Manfred Kraus

SVP, Head of R&D Therapeutics

LinkedIn (Pro only)
F

Firat Ileri

Board Member

J

Joseph Parrella

VP of CMC

P

Pablo Lubroth

Board Observer

View 15 more team members with Pro

Unlock Full Team Directory

Recent News

Kernal Bio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology
Company Size
~360 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro